Kenji Watanabe

16PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunitySocial epidemiologyChemical thermodynamics and energetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 04, 2024
Impact of twice-daily budesonide foam administration on early clinical response and endoscopic remission in patients with ulcerative colitis: a post hoc analysis.

Kenji Watanabe, Fumihito Hirai, Kiyonori Kobayashi

|Nov 29, 2023
Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study.

Kenji Watanabe, Laurent Peyrin-Biroulet, Silvio Danese

|Aug 10, 2023
Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study, J-COMBAT.

Kenji Watanabe, Masanori Nojima, Hiroshi Nakase

|Mar 04, 2023
Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn's Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn's Disease (iCREST-CD).

Takayuki Yamamoto, Hiroshi Nakase, Kenji Watanabe

|Sep 23, 2022
Darvadstrocel for Complex Perianal Fistulas in Japanese Adults with Crohn's Disease: A Phase 3 Study.

Satomi Furukawa, Tsunekazu Mizushima, Ryo Nakaya

|Sep 08, 2022
Guidelines for endoscopic balloon dilation in treating Crohn's disease-associated small intestinal strictures (supplement to the Clinical Practice Guidelines for Enteroscopy).

Hironori Yamamoto, Tomonori Yano, Akihiro Araki

Pageof 3

Frequent Collaborators

5 joint publications

Fumihito Hirai

4 joint publications

Sakiko Hiraoka

4 joint publications

Hiroshi Nakase

3 joint publications

Makoto Naganuma